Literature DB >> 21518759

Integrin regulation of beta-catenin signaling in ovarian carcinoma.

Rebecca J Burkhalter1, Jaime Symowicz, Laurie G Hudson, Cara J Gottardi, M Sharon Stack.   

Abstract

Reversible modulation of integrin-regulated cell-matrix adhesion and epithelial (E)-cadherin-mediated cell-cell adhesion plays a critical role in the establishment of ovarian cancer metastases. In contrast to most epithelial cell-derived tumors that down-regulate E-cadherin expression during progression, acquisition of E-cadherin expression accompanies malignant transformation of the ovarian surface epithelium and is maintained in peritoneal metastases. Metastatic epithelial ovarian cancer cells are disseminated intraperitoneally and preferentially adhere via integrins to interstitial collagens in the peritoneal cavity. This study was undertaken to determine whether integrin engagement influences E-cadherin and β-catenin localization and function. The data demonstrate that multivalent integrin engagement results in increased internalization of E-cadherin, inhibition of GSK-3β, elevated levels of nuclear β-catenin, increased β-catenin-regulated promoter activation, and transcriptional activation of Wnt/β-catenin target genes. Blocking β-catenin transcriptional control with inhibitor of β-catenin and Tcf-4 reduces cellular invasion, suggesting a key role for β-catenin nuclear signaling in EOC invasion and metastasis. These studies support a model wherein cell-matrix engagement regulates the functional integrity of cell-cell contacts, leading to increased β-catenin nuclear signaling and enhanced cellular invasive activity. Furthermore, these results provide a mechanism for activation of Wnt/β-catenin signaling in the absence of activating mutations in this pathway.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21518759      PMCID: PMC3123110          DOI: 10.1074/jbc.M110.199539

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  77 in total

1.  Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.

Authors:  D A Fishman; Y Liu; S M Ellerbroek; M S Stack
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

Review 2.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

3.  Functional interplay between type I collagen and cell surface matrix metalloproteinase activity.

Authors:  S M Ellerbroek; Y I Wu; C M Overall; M S Stack
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

4.  Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases.

Authors:  E Daraï; J Y Scoazec; F Walker-Combrouze; N Mlika-Cabanne; G Feldmann; P Madelenat; F Potet
Journal:  Hum Pathol       Date:  1997-08       Impact factor: 3.466

5.  Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.

Authors:  Maria V Barbolina; Brian P Adley; David L Kelly; Jaclyn Shepard; Angela J Fought; Denise Scholtens; Peter Penzes; Lonnie D Shea; M Sharon Stack
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

6.  Role of glycosidases in human ovarian carcinoma cell mediated degradation of subendothelial extracellular matrix.

Authors:  M J Niedbala; R Madiyalakan; K Matta; K Crickard; M Sharma; R J Bernacki
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

7.  Calcium regulation of matrix metalloproteinase-mediated migration in oral squamous cell carcinoma cells.

Authors:  Hidayatullah G Munshi; Yi I Wu; Edgardo V Ariztia; M Sharon Stack
Journal:  J Biol Chem       Date:  2002-08-22       Impact factor: 5.157

8.  Mutational analysis of beta-catenin gene in Japanese ovarian carcinomas: frequent mutations in endometrioid carcinomas.

Authors:  S Sagae; K Kobayashi; Y Nishioka; M Sugimura; S Ishioka; M Nagata; K Terasawa; T Tokino; R Kudo
Journal:  Jpn J Cancer Res       Date:  1999-05

9.  Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools.

Authors:  Yoonseok Kam; Vito Quaranta
Journal:  PLoS One       Date:  2009-02-24       Impact factor: 3.240

10.  Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours.

Authors:  Y Wang; S M Hewitt; S Liu; X Zhou; H Zhu; C Zhou; G Zhang; L Quan; J Bai; N Xu
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

View more
  31 in total

1.  Integrin antagonist augments the therapeutic effect of adenovirus-mediated REIC/Dkk-3 gene therapy for malignant glioma.

Authors:  Y Shimazu; K Kurozumi; T Ichikawa; K Fujii; M Onishi; J Ishida; T Oka; M Watanabe; Y Nasu; H Kumon; I Date
Journal:  Gene Ther       Date:  2014-11-13       Impact factor: 5.250

Review 2.  Mechano-reciprocity is maintained between physiological boundaries by tuning signal flux through the Rho-associated protein kinase.

Authors:  Sarah T Boyle; Michael S Samuel
Journal:  Small GTPases       Date:  2016-05-11

3.  Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.

Authors:  Rebecca J Burkhalter; Suzanne D Westfall; Yueying Liu; M Sharon Stack
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

4.  GINS2 regulates cell proliferation and apoptosis in human epithelial ovarian cancer.

Authors:  Ting Yan; Wentong Liang; Enli Jiang; Aizhu Ye; Qian Wu; Mingrong Xi
Journal:  Oncol Lett       Date:  2018-06-11       Impact factor: 2.967

Review 5.  E-cadherin's dark side: possible role in tumor progression.

Authors:  Fausto J Rodriguez; Laura J Lewis-Tuffin; Panos Z Anastasiadis
Journal:  Biochim Biophys Acta       Date:  2012-03-13

6.  Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells.

Authors:  Zuzana Saidak; Carole Le Henaff; Sofia Azzi; Caroline Marty; Sophie Da Nascimento; Pascal Sonnet; Pierre J Marie
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

7.  Inhibition of ovarian cancer proliferation and invasion by pachymic acid.

Authors:  Ai-Hua Gao; Liang Zhang; Xin Chen; Ying Chen; Zhen-Zhen Xu; Ya-Nan Liu; Hong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

8.  MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling.

Authors:  Panagiota Giannakouros; Marina Comamala; Isabelle Matte; Claudine Rancourt; Alain Piché
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

9.  Axin pathway activity regulates in vivo pY654-β-catenin accumulation and pulmonary fibrosis.

Authors:  Arnau Ulsamer; Ying Wei; Kevin K Kim; Kevin Tan; Sarah Wheeler; Ying Xi; R Scott Thies; Harold A Chapman
Journal:  J Biol Chem       Date:  2011-12-27       Impact factor: 5.157

10.  Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein.

Authors:  Maria V Barbolina; Yiuying Liu; Hilal Gurler; Mijung Kim; Andre A Kajdacsy-Balla; Lisa Rooper; Jaclyn Shepard; Michael Weiss; Lonnie D Shea; Peter Penzes; Matthew J Ravosa; M Sharon Stack
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.